ArticleCureus2025
Atypical Presentation of Insulinoma in a Patient With Hypoglycemia Unawareness: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Insulinomas are uncommon tumors in the pancreas that result in the overproduction of insulin, which can cause frequent episodes of low blood sugar. While most patients present with typical symptoms such as confusion and diaphoresis, some may experience hypoglycemia unawareness. This occurs when repeated episodes of low blood glucose impair the body's autonomic responses, making it difficult for the patient to recognize early signs of impending hypoglycemia. As a result, diagnosis can be delayed, increasing the risk of severe complications such as seizures, coma, or accidents. We present the case of a 69-year-old male diagnosed with insulinoma after a motor vehicle accident, which revealed a dangerously low blood glucose level of 2.8 mmol/L, despite the patient reporting no symptoms. Further investigations, including a supervised 72-hour fast, showed abnormally high C-peptide (1,350 pmol/L) and insulin (14 mU/L) levels, with a lab glucose reading of 2.2 mmol/L. A CT scan of the pancreas revealed a 1.25 cm enhancing lesion in the proximal body, consistent with an insulinoma. The patient underwent a successful Whipple procedure, and his postoperative recovery was uneventful. This case highlights the diagnostic challenges of insulinomas, especially in patients with hypoglycemia unawareness. It underscores the importance of considering insulinoma in the differential diagnosis of patients presenting with hypoglycemia unawareness. Early recognition and intervention are crucial to prevent serious complications associated with this condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.